At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 20 enrolled

Drug / intervention

Emtricitabine / Tenofovir Disoproxil Oral Tablet +1 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03387462

NCT03387462Phase 4Completed

Compare CT.gov

DOT Diary (D2): Developing a Mobile App With Combined Automated DOT and Daily Sexual Diary for Monitoring and Improving PrEP Adherence: DOT Diary Optimization Pilot

Public Health Foundation Enterprises, Inc.·interventional·Posted Jan 2, 2018·Updated Oct 27, 2021

In Brief

A Phase 4 clinical trial evaluating Emtricitabine / Tenofovir Disoproxil Oral Tablet and DOT Diary mobile app for Adherence, Medication and 3 related conditions. Completed, enrolled 20 participants across 2 sites.

Detailed Summary

The researchers are working with a technology company, AiCure, to develop a smartphone app, DOT Diary, which combines two drug adherence strategies. DOT Diary reminds people when it is time to take their medication, and uses motion-sensing technology to visually and automatically confirm the pill was swallowed. The goal of this study is to understand people's experiences using this new app while taking HIV pre-exposure prophylaxis (PrEP) for the prevention of HIV.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsAdherence, Medication, Risk Behavior, Pre-Exposure Prophylaxis, HIV Prevention

CountriesUnited States

CollaboratorsNational Institute of Mental Health (NIMH), San Francisco Department of Public Health, Emory University, AiCure

Timeline

Phase 4CompletedFinished

201820192020202120222023202420252026

First PostedJan 2018

Enrollment StartFeb 2018

Primary CompletionAug 2018

TodayJul 2026

First PostedJan 2, 2018

Enrollment StartFeb 28, 2018

Primary CompletionAug 30, 2018

TodayJul 2, 2026

Enrollment to primary: 6 monthsPosted 8.5 years ago

Interventions

Emtricitabine / Tenofovir Disoproxil Oral Tabletdrug

Open label daily emtricitabine/tenofovir disoproxil oral tablet

DOT Diary mobile appother

DOT Diary mobile application for tracking medication adherence and sexual activities.